Colonoscopic screening for colorectal cancer
Ontology highlight
ABSTRACT: Intervention 1: Intervention group: Colonoscopy. The subjects will receive screening colonoscopic examination. In case of any abnormal pathological findings, appropriate treatment will be considered for the subject. Intervention 2: Control group: No colonoscopy.
Primary outcome(s): Incidence of Colorectal cancer. Timepoint: 3 years. Method of measurement: All participants in the intervention and control groups will be followed annually. Each subject will annually be contacted by a telephone call, and questions about the subject’s vital status and cancer incidence will be asked. If there is any possible evidence of developing cancer or death in each subject, the follow up team will collect supportive documents (from patient’s hospital files,...) to define the exact cause of death or type of cancer.
Study Design: Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Screening.
DISEASE(S): Malignant Neoplasm Of Colon, Unspecified,Colorectal Cancer
PROVIDER: 2478403 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA